Abstract:While protein coronas (PCs) are an important barrier in the clinical application of nanomedicines, the specific effects of PCs on nanoparticles (NPs) in vivo are unclear. Herein, we demonstrated that PCs from clinical sources greatly influenced the active targeting capacities of transferrin-modified NPs (Tf-NPs). Compared to PCs from healthy volunteers, PCs from the plasma of patients with nonsmall cell lung cancer (NSCLC) decreased the A549 uptake of Tf-NPs to a greater degree. The PC proteome revealed that this difference may be mediated by certain proteins in plasma. To attenuate the negative influence of PCs from patients, precoating Tf-NPs with PCs derived from healthy mice significantly enhanced active targeting capacities. Paclitaxel-loaded Tf-NPs with PCs derived from healthy mice showed the strongest antitumor effects in mice with NSCLC. This work illustrates the influence of PCs of ligand-modified NPs in clinical practice and proposes the use of corona-enabled active targeting for precision nanomedicine.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.nanolett.0c03982?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.nanolett.0c03982</a>.Details related to materials and methods; characterization of particle size and zeta (ζ) potential of bare NPs and NPs with PC (Table S1); the amount of protein adsorbed on NPs (Table S2); the most abundant proteins (top 30) identified in the PC of NPs from human sources (Table S3); the most abundant proteins (top 30) identified in the PC of NPs from murine sources (Table S4); microscopic observation of coumarin+ A549 cells (Figures S1 and S3); normalized fluorescence intensity in A549 cells (Figures S2 and S4); schematic description of the experimental design for studies of in vivo mouse PC formation (Figure S5); the intensity diameter distribution of NPs with/without in vivo mouse-derived PC (Figure S6); TEM images of NPs with/without in vivo mouse-derived PC (Figure S7); microscopy observation of coumarin+ LL/2 cells (Figures S8 and S10); the normalized fluorescence intensity in LL/2 cells (Figures S9 and S11); fluorescence intensity in organs and tumor 24 h post-injection (Figure S12); tumor size in all mouse groups (Figure S13); coomassie brilliant blue-stained SDS-PAGE gel of PCs associated with NPs (Figure S14); classification of PCs according to physiological function (Figure S15); Venn diagrams depicting the number of unique proteins identified in the in vitro-formed coronas and their respective overlap (Figure S16); Venn diagrams depicting the number of unique proteins identified in the in vivo-formed coronas and their respective overlap (Figure S17); and evaluation of NP safety and IgE concentrations in serum from all murine groups (Figure S18) (<a class="ext-link" href="/doi/suppl/10.1021/acs.nanolett.0c03982/suppl_file/nl0c03982_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Combinatory Interpretation of Protein Corona and Shear Stress for Active Cancer Targeting of Bioorthogonally Clickable Gelatin-Oleic Nanoparticles.

Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy

Impact of Protein Corona and PEGylation on the Accumulation and Efficacy of Lysosome-Disrupting Lipid Nanoparticles in KRAS-mutated Cancer

Enhanced Cancer-targeted Drug Delivery Using Precoated Nanoparticles

Design and Evaluation of Clickable Gelatin-Oleic Nanoparticles Using Fattigation-Platform for Cancer Therapy

The Impact of Protein Corona on the Behavior and Targeting Capability of Nanoparticle-Based Delivery System.

Molecular dynamics of core-shell micelles interaction with anticancer drugs and corona proteins.

Harnessing the Protein Corona towards Surface Design for Nanoparticle Tumor Delivery

Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties

Effects of Protein Corona on Active and Passive Targeting of Cyclic RGD Peptides Functionalized PEGylation Nanoparticles.

The Janus of Protein Corona on Nanoparticles for Tumor Targeting, Immunotherapy and Diagnosis

An investigation of the effect of the protein corona on the cellular uptake of nanoliposomes under flow conditions using quartz crystal microgravimetry with dissipation

Protein Corona on Magnetite Nanoparticles and Internalization of Nanoparticle–protein Complexes into Healthy and Cancer Cells

Protein corona potentiates recovery of nanoparticle-induced disrupted tight junctions in endothelial cells

The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery.

The role of patient-specific variables in protein corona formation and therapeutic efficacy in nanomedicine

Effect of Protein Corona on Mitochondrial Targeting Ability and Cytotoxicity of Triphenylphosphonium Conjugated with Polyglycerol-Functionalized Nanodiamond.

In situ low-immunogenic albumin-conjugating-corona guiding nanoparticles for tumor-targeting chemotherapy

Characterization and Biomedical Application Opportunities of the Nanoparticle's Protein Corona

The impact of protein corona on the biological behavior of targeting nanomedicines

Regulation of protein corona on liposomes using albumin-binding peptide for targeted tumor therapy